| 1 |
35158093 | Phosphoproteome of signaling by ErbB2 in ovarian cancer cells. | 2022 Apr 1 |
1 |
| 2 |
35388067 | Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study. | 2022 Apr 6 |
3 |
| 3 |
35454074 | In Search of Differential Inhibitors of Aldose Reductase. | 2022 Mar 22 |
2 |
| 4 |
32208122 | Exploration of Diosmin to Control Diabetes and Its Complications-an In Vitro and In Silico Approach. | 2021 |
1 |
| 5 |
32734850 | Inhibitory effects of curcumin on aldose reductase and cyclooxygenase-2 enzymes. | 2021 Oct |
2 |
| 6 |
33494154 | Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems. | 2021 Jan 21 |
2 |
| 7 |
25376835 | Reduction of lipid peroxidation products and advanced glycation end-product precursors by cyanobacterial aldo-keto reductase AKR3G1—a founding member of the AKR3G subfamily. | 2015 Jan |
1 |
| 8 |
25532697 | Structural analysis of sulindac as an inhibitor of aldose reductase and AKR1B10. | 2015 Jun 5 |
1 |
| 9 |
24817585 | Identification and functional characterization of sorbitol-6-phosphate dehydrogenase protein from rice and structural elucidation by in silico approach. | 2014 Jul |
1 |
| 10 |
24974084 | Induced fit docking, pharmacophore modeling, and molecular dynamic simulations on thiazolidinedione derivatives to explore key interactions with Tyr48 in polyol pathway. | 2014 Jul |
3 |
| 11 |
23295227 | X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity. | 2013 Feb 25 |
1 |
| 12 |
22249747 | Pharmacophore modeling, molecular docking, and molecular dynamics simulation approaches for identifying new lead compounds for inhibiting aldose reductase 2. | 2012 Jul |
2 |
| 13 |
22505406 | Structure of the His269Arg mutant of the rat aldose reductase-like protein AKR1B14 complexed with NADPH. | 2012 Apr 1 |
2 |
| 14 |
21306562 | Catalytic mechanism of the primary human prostaglandin F2α synthase, aldo-keto reductase 1B1--prostaglandin D2 synthase activity in the absence of NADP(H). | 2011 Apr |
5 |
| 15 |
21319207 | Synthesis and biological evaluation of 2'-oxo-2,3-dihydro-3'H- spiro[chromene-4,5'-[1,3]oxazolidin]-3'yl]acetic acid derivatives as aldose reductase inhibitors. | 2011 Jun |
2 |
| 16 |
21859105 | Electrostatic fields near the active site of human aldose reductase: 2. New inhibitors and complications caused by hydrogen bonds. | 2011 Oct 4 |
1 |
| 17 |
20218967 | 3D-QSAR Studies on a Series of 5-Arylidine-2, 4-Thiazolidinediones as Aldose Reductase Inhibitors: A Self-Organizing Molecular Field Analysis Approach. | 2010 Mar 11 |
2 |
| 18 |
20402658 | 3D-QSAR studies on a series of 5-arylidine-2, 4-thiazolidinediones as aldose reductase inhibitors: a self-organizing molecular field analysis approach. | 2010 Jan |
2 |
| 19 |
19010934 | Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7. | 2009 Feb |
1 |
| 20 |
19013440 | Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes. | 2009 Mar 16 |
3 |
| 21 |
19301313 | Structure-based optimization of aldose reductase inhibitors originating from virtual screening. | 2009 May |
2 |
| 22 |
19602579 | Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy. | 2009 Sep |
1 |
| 23 |
18451330 | Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis. | 2008 Jun |
2 |
| 24 |
18537622 | From a dull enzyme to something else: facts and perspectives regarding aldose reductase. | 2008 |
1 |
| 25 |
16622654 | Comparison of hydrogen determination with X-ray and neutron crystallography in a human aldose reductase-inhibitor complex. | 2006 Sep |
1 |
| 26 |
17139089 | Ultrahigh-resolution study of protein atomic displacement parameters at cryotemperatures obtained with a helium cryostat. | 2006 Dec |
1 |
| 27 |
15769597 | The structure of Apo R268A human aldose reductase: hinges and latches that control the kinetic mechanism. | 2005 May 15 |
3 |
| 28 |
15146478 | Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A. | 2004 Jun 1 |
1 |
| 29 |
12604217 | Hydrogen bonding interactions between aldose reductase complexed with NADP(H) and inhibitor tolrestat studied by molecular dynamics simulations and binding assay. | 2003 Feb 1 |
8 |
| 30 |
12604221 | Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. | 2003 Feb 1 |
1 |
| 31 |
12732097 | Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. | 2003 Aug 1 |
2 |
| 32 |
12855766 | Electrostatic complementarity in an aldose reductase complex from ultra-high-resolution crystallography and first-principles calculations. | 2003 Jul 22 |
1 |
| 33 |
12871133 | Recent studies of aldose reductase enzyme inhibition for diabetic complications. | 2003 Aug |
2 |
| 34 |
12871134 | Aldose reductase inhibitors from the nature. | 2003 Aug |
2 |
| 35 |
14615967 | Aldose reductase catalyzes reduction of the lipid peroxidation product 4-oxonon-2-enal. | 2003 Nov |
1 |
| 36 |
14641065 | Aldose reductase and the importance of experimental design. | 2003 Dec |
3 |
| 37 |
11958479 | Aldose reductase: an aldehyde scavenging enzyme in the intraneuronal metabolism of norepinephrine in human sympathetic ganglia. | 2002 Mar 18 |
1 |
| 38 |
11444967 | Stereospecific interaction of a novel spirosuccinimide type aldose reductase inhibitor, AS-3201, with aldose reductase. | 2001 Jul 27 |
2 |
| 39 |
12164386 | Aldose reductase inhibitors. | 2001 Dec |
1 |
| 40 |
10706394 | Inhibitory effects of fidarestat on aldose reductase and aldehyde reductase activity evaluated by a new method using HPLC with post-column spectrophotometric detection. | 2000 Feb |
1 |
| 41 |
10933817 | The sorbinil trap: a predicted dead-end complex confirms the mechanism of aldose reductase inhibition. | 2000 Aug 15 |
1 |
| 42 |
10997684 | Aldose reductase and the role of the polyol pathway in diabetic nephropathy. | 2000 Sep |
4 |
| 43 |
9884310 | Aldose reductase catalyzes the oxidation of naphthalene-1, 2-dihydrodiol for the formation of ortho-naphthoquinone. | 1999 Jan |
1 |
| 44 |
10493777 | Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites. | 1999 Sep 3 |
1 |
| 45 |
9546197 | Catalytic mechanism of aldose reductase studied by the combined potentials of quantum mechanics and molecular mechanics. | 1998 Mar 9 |
1 |
| 46 |
9871575 | Molecular dynamics simulations of the structure of aldose reductase complexed with the inhibitor tolrestat. | 1998 Mar 17 |
1 |
| 47 |
9000650 | Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium. | 1997 |
2 |
| 48 |
9195881 | A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil. | 1997 May 15 |
4 |
| 49 |
9307017 | NAD(P)H-dependent aldose reductase from the xylose-assimilating yeast Candida tenuis. Isolation, characterization and biochemical properties of the enzyme. | 1997 Sep 15 |
1 |
| 50 |
9398310 | Modification of aldose reductase by S-nitrosoglutathione. | 1997 Dec 16 |
1 |